Close Menu

NEW YORK (360Dx) – Hologic announced after the close of the market on Tuesday that it has completed the sale of its stake in blood screening firm Grifols for $1.85 billion.

At the time the deal was announced in December, Hologic Chairman, President, and CEO Steve MacMillan said that Grifols, while having excellent value for a non-core business, nonetheless, "was a drag on our growth" and operated in a challenging market with ongoing headwinds.  

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.